Analyst Schimmer holds a conference call to discuss the CF Gene Therapy Program with Co-Founder & CEO Kirn and CFO Mehra on November 6 at 11 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FDMT:
- 4DMT provides data from Phase 1/2 AEROW trial of aerosolized 4D-710 for CF
- 4D Molecular to hold a conference call
- 4D announces plan to lift clinical hold on Phase 1/2 INGLAXA trial for 4D-310
- Microsoft upgraded, F5 Networks downgraded: Wall Street’s top analyst calls
- 4D Molecular initiated with an Outperform at RBC Capital